Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P634: Real-world data on the efficacy and safety of vedolizumab therapy in patients with inflammatory bowel disease: a retrospective nation-wide cohort study in Singapore

ECCO '19 Copenhagen

Year: 2019
Authors:

A. T-M. Gan*1, W. P-W. Chan1, K. L. Ling1,2, L. J. Hartono3, D. E. Ong3, M. Gowans3, H. Lin4, W. C. Lim4, M. T-K. Tan5, J. P-L. Ong5, B. J. Schwender1, S. C. Kong1, W. C. Ong1, T. G. Lim1, S. W. Chuah6, C. J. Ooi6, H. H. Shim1

1Singapore General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, 2Mount Elizabeth Hospital, Singapore, Singapore, 3National University Hospital, Division of Gastroenterology and Hepatology, Singapore, Singapore, 4Tan Tock Seng Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, 5Changi General Hospital, Department of Gastroenterology and Hepatology, Singapore, Singapore, 6Gleneagles Hospital, Singapore, Singapore

P635: Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Guardiola*1,2, L. Rodriguez Alonso1, E. Santacana3, A. Padró4, K. Serra1, N. Padullés3, A. Ruiz-Cerulla1, P. Gilabert1, C. Arajol1, G. Ibañez-Sanz1, B. Camps1, J. Orobitg1, A. Serracarbasa1, L. de la Peña1, A. Berrozpe1, F. Rodriguez Moranta1

1Hospital Universitari de Bellvitge, Gastroenterology, L’Hospitalet de Llobregat, Spain, 2Universitat de Barcelona, Barcelona, Spain, 3Hospital Universitari de Bellvitge, Pharmacy, L’Hospitalet de Llobregat, Spain, 4Hospital Universitari de Bellvitge, Clinical Genetics Laboratory, L’Hospitalet de Llobregat, Spain

P636: Impact of anti-TNF treatment on extra-intestinal manifestations in patients with inflammatory bowel disease: real-world data in Germany

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Bettenworth*1, W-J. Lee2, R. S. Clark2, S. Rath3, M. Yang4, A. Bensimon4, S. Vavricka5

1University Hospital Munster, Department of Medicine B - Gastroenterology and Hepatology, Munster, Germany, 2AbbVie Inc., North Chicago, United States, 3AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 4Analysis Group, Inc., Boston, USA, 5Triemli Hospital, Zentrum fur Gastroenterologie und Hepatologie, Department of Medicine, Division of Gastroenterology, Zurich, Switzerland

P637: MMP-2 and -8 degraded and citrullinated-vimentin (VICM) correlates to disease activity in inflammatory bowel diseases

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Godskesen1, M. Lindholm2, J. Høg Mortensen2, A. Krag1, T. Manon-Jensen2, M. Karsdal2, J. Kjeldsen1

1Odense University Hospital, Department of Medical Gastroenterology, Odense, Denmark, 2Nordic Bioscience, Biomarkers and Research, Herlev, Denmark

P638: BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, does not affect the pharmacokinetics of methotrexate in healthy subjects

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Chimalakonda*1, J. Jones III2, R. Dockens1, J. Throup1, S. Banerjee1, I. Girgis1

1Bristol-Myers Squibb, Princeton, United States, 2PRA Health Sciences, Blue Bell, United States

P639: Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Theodoraki*1, E. Orfanoudaki1, K. Foteinogiannopoulou1, E. Legaki2, M. Gazouli2, I. Koutroubakis1

1University Hospital of Heraklion, Gastroenterology Department, Heraklion, Greece, 2Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

P640: Evaluation of dietetic services and the impact of diet on disease activity for patients with inflammatory bowel disease at Imperial College Healthcare NHS Trust

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Sandhar*1, N. Direkze2, S. Peake2

1Imperial College London, Faculty of Medicine, London, UK, 2Imperial College Healthcare NHS Trust, Gastroenterology, London, UK

P641: Ustekinumab efficiency as a higher-line therapy in association with serum levels in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Kolar*1, K. Pudilova1, M. Bortlik1,2,3, D. Duricova1, K. Malickova1,4, M. Lukas1, V. Hruba1, N. Machkova1, R. Vanickova1, K. Mitrova1, M. Vasatko1, M. Lukas1,4

1ISCARE I.V.F. a.s., IBD Clinical and Research Centre, Prague, Czech Republic, 2Military University Hospital and First Faculty of Medicine, Charles University, Department of Internal Medicine, Prague, Czech Republic, 3Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 4Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic

P642: Anxiety and depression: beyond simple consequences of chronic inflammatory bowel diseases

ECCO '19 Copenhagen

Year: 2019
Authors:

O. Timofte*1, E. Gologan1, A. S. Leca2, G-E. Galca-Blanariu1,2, G. Stefanescu1,2

1‘Gr.T Popa’ Medicine and Pharmacy University, Medical Semiology and Gastroenterology, Iasi, Romania, 2Institute of Gastroenterology and Hepatology, Iasi, Romania

P643: Effectiveness of enhanced recovery after surgery in IBD: a propensity score matched cohort study in a single Italian centre

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Mineccia1, M. Daperno*2, P. Massucco1, F. Menonna1, V. Gentile1, P. Germani1, M. Mendolaro2, R. Rocca2, A. Ferrero1

1Mauriziano Hospital, Surgery, Turin, Italy, 2Mauriziano Hospital, Gastroenterology Unit, Torino, Italy

P644: Mindfulness-based stress reduction in adult patients with active Crohn's disease: preliminary findings based on the subjective units of distress scale: an IIRN study

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Schwartz*1, G. Goren2, P. Perpinial2, M. Friger3, O. Sarid2, V. Slonim-Nevo2, R. Sergienko3, A. Nemirovsky4, E. Vinogradov4, D. Greenberg6, A. Monsonego4, D. Turner7, A. Eliakim8, S. Ben Horin8, Y. Chowers9, H. Yanai10, I. Dotan10, S. Odes1

1Soroka Medical Center, Gastroenterology, Beer Sheva, Israel, 2Ben-Gurion University of the Negev, Social Work, Beer Sheva, Israel, 3Ben-Gurion University of the Negev, Public Health, Beer Sheva, Israel, 4Ben-Gurion University of the Negev, Microbiology, Immunology and Genetics, Beer Sheva, Israel, 6Ben-Gurion University of the Negev, Health Systems Management, Beer Sheva, Israel, 7Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel, 8Sheba Medical Center, Gastroenterology, Tel Hashomer, Israel, 9Rambam Health Care Campus, Gastroenterology, Haifa, Israel, 10Rabin Medical Center, Gastroenterology, Petach Tikva, Israel

P645: Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Guardiola*1,2, L. Rodriguez Alonso1, N. Padullés3, E. Santacana3, K. Serra1, A. Padulles3, A. Ruiz-Cerulla1, P. Gilabert1, C. Arajol1, G. Ibañez-Sanz1, B. Camps1, H. Colom2, J. Bas4, F. Morandeira4, E. Sanchez1, J. Orobitg1, F. Rodriguez Moranta1

1Hospital Universitari de Bellvitge, Gastroenterology, L’Hospitalet de Llobregat, Spain, 2Universitat de Barcelona, Barcelona, Spain, 3Hospital Universitari de Bellvitge, Pharmacy, L’Hospitalet de Llobregat, Spain, 4Hospital Universitari de Bellvitge, Immunology, L’Hospitalet de Llobregat, Spain

P646: Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Department of Pathology, Negrar, Italy, 4Mount Sinai Hospital University of Toronto, Department of Pathology and Laboratory Medicine, Toronto, Canada

P647: A pilot study: The importance of cognitive flexibility and flexibility in coping with stress for the quality of life in inflammatory bowel disease patients during biological therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Rudnik*1,2, G. Piotrowicz2, M. Basińska3, G. Rydzewska4,5, V. Rashedi6,7

1University of Gdansk, Institute of Psychology, Gdansk, Poland, 2Independent Public Health Care of the Ministry of the Internal Affairs, Department of Gastroenterology, Gdansk, Poland, 3Kazimierz Wielki University, Department of Clinical Psychology, Bydgoszcz, Poland, 4Central Clinical Hospital of the Ministry of Interior and Administration, Department of Gastroenterology, Warsaw, Poland, 5Jan Kochanowski University, The Faculty of Medicine and Health Sciences, Kielce, Poland, 6Iran University of Medical Sciences, School of Behavioral Sciences and Mental Health (Tehran Institute of Psychiatry), Tehran, Iran, Islamic Republic of, 7University of Social Welfare and Rehabilitation Sciences, Iranian Research Centre on Aging, Tehran, Iran, Islamic Republic of

P648: Anti-TNF-α therapy, use of corticosteroids, and colectomy among paediatric and adolescent patients with ulcerative colitis: a nationwide study

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Lund*1,2, M. D. Larsen1, T. Knudsen3,4, J. Kjeldsen5,6, R. G. Nielsen7,8, B. M. Noergaard1,2

1Odense University Hospital, Center for Clinical Epidemiology, Odense, Denmark, 2University of Southern Denmark, Department of Clinical Research, Research unit of Clinical Epidemiology, Odense, Denmark, 3Hospital of Southwest Jutland, Department of Medicine, Esbjerg, Denmark, 4University of Southern Denmark, Institute for Regional Health Science, Center Southwest Jutland, Esbjerg, Denmark, 5Odense University Hospital, Department of Medical Gastroenterology S, Odense, Denmark, 6University of Southern Denmark, Department of Clinical Research, Research unit of Medical Gastroenterology, Odense, Denmark, 7Odense University Hospital, Hans Christian Andersen Children's Hospital, Odense, Denmark, 8University of Southern Denmark, Department of Clinical Research, Research unit of Pediatrics, Odense, Denmark

P649: Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Visuri*1, C. Eriksson1, E. Mårdberg1, O. Grip2, A. Gustavsson3, H. Hjortswang4,5, P. Karling6, S. Montgomery7,8,9, P. Myrelid4,10, O. Olén9,11,12, The SWIBREG Study Group1, J. F. Ludvigsson13,14, J. Halfvarson1

1Örebro University, Department of Gastroenterology, Faculty of Medicine and Health, Örebro, Sweden, 2Skåne University Hospital, Department of Gastroenterology, Malmö, Sweden, 3Central Hospital, Department of Internal Medicine, Karlstad, Sweden, 4Linköping University, Department of Clinical and Experimental Medicine, Linköping, Sweden, 5Linköping University, Department of Gastroenterology, Linköping, Sweden, 6Umeå University, Department of Public Health and Clinical Medicine, Umeå, Sweden, 7Örebro University, Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro, Sweden, 8University College London, Department of Epidemiology and Public Health, London, UK, 9Karolinska Institutet, Clinical Epidemiology Unit, Department of Medicine Solna, Stockholm, Sweden, 10Linköping University Hospital, Department of Surgery, Linköping, Sweden, 11Stockholm South General Hospital, Sachs’ Children and Youth Hospital, Stockholm, Sweden, 12Karolinska Institutet, Department of Clinical Science and Education Södersjukhuset, Stockholm, Sweden, 13Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden, 14Örebro University Hospital, Department of Pediatrics, Örebro, Sweden

P650: Mechanisms of Infliximab failure: the predictive role of MMP3

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Barberio*1, R. D'Incà2, S. Facchin3, M. Dalla Gasperina1, C. Fohom1, R. Cardin1, E. Savarino2, F. Zingone1

1Dr., Gastroenterology, Padova, Italy, 2University of Padua, Department of Oncological Gastrointestinal Surgery, Padova, Italy, 3University of Padua, Department of Surgery, Oncology and Gastroenterology, Gastroenterology Section, Padova, Italy

P651: Disease severity and intensity of therapy predicts serious adverse events in paediatric ulcerative colitis: the DEVELOP experience

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Winter*1, J. Izanec2, C. Busse2, Y. Wang3, J. Hyams4

1MassGeneral Hospital for Children, Boston, USA, 2Janssen Scientific Affairs, LLC, Horsham, USA, 3Janssen Research & Development, LLC, Spring House, USA, 4Connecticut Children’s Medical Center, Hartford, USA

P652: Compare risk factors associated with infectious complication in Crohn’s disease with and without preoperative infliximab

ECCO '19 Copenhagen

Year: 2019
Authors:

X. Ge*1, Q. Cao2, W. Zhou1

1Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, General Surgery, Hangzhou, China, 2Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Department of Gastroenterology, Hangzhou, China

P653: Ligation of the intersphincteric fistula tract vs. endorectal advancement flap for high perianal fistulas in Crohn’s disease: a retrospective cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

E. van Praag*1, M. Stellingwerf1, J. van der Bilt1, K. Gecse2, W. Bemelman1, C. Buskens1

1Amsterdam UMC, Surgery, Amsterdam, The Netherlands, 2Amsterdam UMC, Gastroenterology, Amsterdam, The Netherlands